Introduction
While it is generally recognized that excessive exposure of cortical neurons to glutamate under conditions such as traumatic brain injury and stroke can cause cell death and epileptogenesis (glutamate toxicity; Nilsson et al., 1990; Bullock et al., 1995 Bullock et al., , 1998 Dávalos et al., 1997; Smolders et al., 1997; Sun et al., 2001; Rakhade and Jensen, 2009) , the cellular mechanisms underlying such toxicity are not as yet widely understood. We show in this study that glutamate exposure altered synaptically activated group I mGluR responses to facilitate the recruitment of prolonged epileptiform discharges.
Stimulation of group I mGluRs elicits rapid and robust protein synthesis in cortical neurons (Weiler et al., 1997; Osterweil et al., 2010) . Newly synthesized proteins produce long-term changes in synaptic (LTD; Huber et al., 2000) and intrinsic (Chuang et al., 2005; Young et al., 2008; properties of hippocampal neurons in the CA1 and CA3 regions, respectively. The latter changes in the CA3 region underlie enhanced recurrent seizure discharges and epileptogenesis . Enhanced seizure propensity is indicated in vitro by the appearance of synaptically induced prolonged epileptiform discharges in the hippocampus (Chuang et al., 2005; . Prolonged epileptiform discharges are not normal responses elicited synaptically in wild-type hippocampal preparations but are expressed in fragile X syndrome model mouse (Fmr1 Ϫ/Ϫ ) preparations (Chuang et al., 2005; . The appearance of prolonged epileptiform discharges requires aberrantly elevated group I mGluR responses secondary to enhanced protein synthesis (Merlin et al., 1998; Zhao et al., , 2011 Young et al., 2013) .
A key regulator of group I mGluR-stimulated protein synthesis in cortical neurons is fragile X mental retardation protein (FMRP), a translation repressor (Laggerbauer et al., 2001; Li et al., 2001; Bear et al., 2004) . When FMRP is absent, as in the case of fragile X syndrome model mouse (Fmr1 Ϫ/Ϫ ), enhanced protein synthesis elicited by synaptic stimulation of group I mGluRs causes the activation of prolonged epileptiform discharges (Chuang et al., 2005) . Our recent studies show that the function of FMRP itself is regulated by group I mGluRs (Zhao et al., 2011) . Thus, in the wild-type hippocampus, stimulation of group I mGluRs by the agonist DHPG causes proteolysis of FMRP via the ubiquitin-proteasome system (Hou et al., 2006; Zhao et al., 2011; Nalavadi et al., 2012) . In this study, we examined if (1) exposure of hippocampal cells caused FMRP proteolysis via activation of group I mGluRs and (2) with reduced translation repression (due to downregulation of FMRP), synaptic activation of group I mGluRs can activate protein synthesis (Zhao et al., 2011) so that prolonged epileptiform discharges are now activatable by synaptic stimulation.
Materials and Methods

Animals. Fmr1
Ϫ/Ϫ (FVB.129P2-Fmr1 tm1Cgr /J) and control (FVB.129P2-Pde6b ϩ Tyr c-ch /AntJ) mice were purchased from The Jackson Laboratory. Three-week-old male mice were used.
Slice preparation. Transverse hippocampal slices (400 m thick) were prepared as described previously (Chuang et al., 2005) . Briefly, slices were obtained from the dorsal half of each hippocampus. During slicing, the hippocampi were submerged in an ice-cold, low-Ca 2ϩ /high-Mg 2ϩ buffer, consisting of the following (in mM): 124 NaCl, 26 NaHCO 3 , 2.5 KCl, 8 MgCl 2 , 0.5 CaCl 2 , and 10 D-glucose, bubbled with 95% O 2 and 5% CO 2 . After slicing, slices were incubated in a slice-holding chamber maintained at 32.5°C for at least 90 min containing normal solution ACSF consisting of the following (in mM): 124 NaCl, 26 NaHCO 3 , 5 KCl, 1.6 MgCl 2 , 2 CaCl 2 , and 10 D-glucose bubbled with 95% O 2 and 5% CO 2 , pH 7.4. For electrophysiological experiments, slices were subjected to glutamate or drug exposure and then transferred to an interface chamber maintained at 33.5°C. Slices were perfused with ACSF for 60 -90 min before intracellular recording. For Western blot experiments, slices were collected from the sliceholding chamber immediately following drug application. Electrophysiology. Microelectrodes were pulled from glass tubes (1 mm outer diameter with glass filament inside; World Precision Instruments) using a micropipette puller (Sutter Instruments). Microelectrodes were filled with 2 M potassium acetate and the resistances were ϳ70 M⍀. Signals were amplified (Axoclamp 2B; Molecular Devices) and recorded simultaneously in a computer running pClamp 6 (Molecular Devices) and on a chart recorder (Gould).
Drugs. For electrophysiology, pharmacological agents were delivered to the hippocampal slices through continuous perfusion. Depending on the flow rate, the final concentration was reached within 15 min. For Western blot experiments, agents were directly applied to the holding chamber. Pretreatment of slices with various agents lasted for 45 min. Anisomycin, CNQX disodium, CPP, LY367385, were purchased from Tocris Bioscience. Other chemicals were from Sigma. Antibodies for FMRP and ␣-tubulin were purchased from Millipore. Secondary antibodies were from Cell Signaling Technology. MG-132, MPEP, and anisomycin were prepared in DMSO stock solutions. Stock solutions were aliquoted and stored at Ϫ20°C.
Sample preparation. Hippocampal slices were collected from the slice-holding chamber and snap frozen on dry ice. Each sample containing six slices was stored at Ϫ80°C until biochemical analysis. Each sample was sonicated in ice-cold homogenization buffer containing the following (in mM): 320 sucrose, 10 HEPES, pH 7.4, 2 EDTA, 1 EGTA, and protease inhibitors (20 g/ml aprotinin, 20 g/ml leupeptin, 20 g/ml Pepstatin A, and 1 mM PMSF), and phosphatase inhibitors (1 NaF, 1 Na 3 VO 4 , 2.5 Na 4 P 2 O 7 , and 1 ␤-glycerophosphate). The homogenate was then mixed with detergents (final: 0.1% SDS, 0.5% DOC, and 1% NP-40). The suspension was cleared by centrifugation. Lysates were aliquoted and stored at Ϫ80°C. One aliquot of lysate was used to determine protein concentration with BCA method (Fisher Scientific). For Western blots, samples were mixed with SDS sample buffer (10% glycerol, 5% BME, and 2% SDS, in 62 mM Tris-HCl, pH 6.8) and boiled for 5 min.
Western blots. Equal amounts of sample were subjected to electrophoresis in 8% or 10% SDS-PAGE gels (1.0 mm; Novex Tris-Glycine; Invitrogen). Gels were then transferred to PVDF membranes for 1 h at a constant voltage of 100 V (mini Trans-Blot Cell; Bio-Rad). The membrane was stained with Ponceau S briefly to verify the quality of transfer. The membrane was blocked in 5% nonfat milk dissolved in TBST buffer (containing the following: 20 mM Tris-HCl, pH 7.6, 15 mM NaCl, and 0.1% Tween 20) for 1 h at room temperature or overnight at 4°C. After blocking, the membrane was probed with primary antibody for 2 h at room temperature or overnight at 4°C. After incubation, the membrane was washed three times for 5 min each with TBST. The membrane was then incubated with HRP-conjugated secondary antibody in TBST for 1 h. It was washed again three times for 5 min each with TBST, and then the membrane was treated with LumiGLO (Cell Signaling Technology) and developed. Wild-type hippocampal slices were maintained in a slice-holding chamber and exposed to glutamate of increasing concentrations for 30 min. Glutamate effectively decreased FMRP levels at all concentrations tested, and increasing glutamate concentration did not affect either the direction or the amplitude of glutamate-induced changes of FMRP levels. B, Time course of the changes of FMRP levels by glutamate exposure. Slices were collected at 0, 10, and 30 min following the addition of 10 M glutamate. FMRP was quickly decreased by glutamate exposure and reached a plateau level as early as 10 min. C, Effects of mGluR antagonists (100 M LY367385 and 50 M MPEP) on glutamate-induced downregulation of FMRP. In control experiments (ACSF), 10 M glutamate exposure for 30 min significantly decreased FMRP levels (filled column). However, in the presence of mGluR antagonists (LY ϩMPEP), glutamate exposure was no longer effective in eliciting FMRP downregulation. Representative Western blots are displayed above summary data plots. ␣-Tubulin (␣-Tub) levels, used as loading controls, are also displayed. For summary data, the immunoreactivity of FMRP bands was normalized to the immunoreactivity of their corresponding ␣-tubulin bands. For this and the following figures, ***p Ͻ 0.001, **p Ͻ 0.01, and *p Ͻ 0.05.
Data analysis. The duration of an individual synchronized discharge was measured from the beginning of the first action potential of the discharge to the repolarization of the last action potential of the discharge. Discharge durations of all synchronized discharges in a 5 min period for each slice in the various experimental conditions were averaged. Synchronized discharges with durations longer than 1.5 s are referred to as prolonged synchronized discharges. Immunoreactive bands in Western blots were scanned with a desktop scanner (EPSON Expression 1680) and quantified with Scion Image software. The optical densities (ODs) of bands of interest were normalized to the OD value of ␣-tubulin bands. Summary data are reported as means Ϯ SEM. Student's t test was used for the statistical comparison of two sets of data. For analysis of data among groups, one-way ANOVA followed by the Tukey HSD test for repeated measures was applied. In all cases, the level of significant difference was p Ͻ 0.05.
Results
Glutamate exposure downregulates FMRP levels
Previous studies show that stimulation of group I mGluRs elicits FMRP proteolysis (Hou et al., 2006; Zhao et al., 2011; Nalavadi et al., 2012) enabling downstream protein synthesis (Hou et al., 2006; Zhao et al., 2011) . To examine the effects of tonic glutamate exposure on FMRP levels, hippocampal slices were exposed to glutamate at a series of concentrations (10, 100, and 1000 M) for 30 min in a sliceholding chamber. The levels of FMRP in hippocampal slices were evaluated using monoclonal 1C3 antibody. Western blot results (Fig. 1A) revealed that glutamate at the lowest concentration tested was sufficient to induce maximal FMRP reduction during glutamate exposure (at 10 M: 72 Ϯ 6%; at 1000 M: 69 Ϯ 9%; n ϭ 4; p ϭ 0.77).
In parallel experiments, the time course of FMRP level changes by glutamate exposure was examined. Slices were collected at time points of 0, 10, and 30 min after glutamate exposure (10 M). Glutamate induced a rapid decrease of FMRP level ( Fig. 1B ; at 0 min: 98 Ϯ 2%; at 10 min: 80 Ϯ 4%; at 30 min: 70 Ϯ 6%; one-way ANOVA, p Ͻ 0.01; n ϭ 4), and there was no significant difference in FMRP levels between 10 and 30 min (n ϭ 4; p ϭ 0.26).
The receptor involvement in FMRP downregulation by glutamate exposure was examined using group I mGluR antagonists. Slices were treated with LY367385 and MPEP (100 and 50 M, respectively) before (45 min) and during glutamate exposure (10 M for 30 min). FMRP level remained stable when slices were exposed to antagonists alone or to antagonists plus glutamate ( Fig. 1C ; in LY ϩ MPEP alone: 97 Ϯ 3%; in LY ϩ MPEP ϩ Glu: 102 Ϯ 6%; n ϭ 6; p ϭ 0.41). On the other hand, antagonists of AMPA and NMDA receptors (CNQX and CPP, 20 M each) did not affect FMRP downregulation during glutamate exposure (in CNQX ϩ CPP alone: 98 Ϯ 4%; in CNQX ϩ CPP ϩ Glu: 96 Ϯ 3%; n ϭ 4; p ϭ 0.75). . Distinct prolonged epileptiform discharges were elicited in glutamate-exposed slices. Slices were maintained in a slice-holding chamber (filled horizontal bar) for glutamate exposure, and then transferred to an interface chamber for continuous bicuculline perfusion (empty horizontal bar). A, Representative intracellular recordings obtained at 0, 10, and 40 min following the addition of 50 M Bic to the perfusion solution. Aa, In control slices, bicuculline elicited stable, short epileptiform discharges (Bic 10 min), and the short epileptiform discharges remained stable with continuous bicuculline perfusion (Bic 40 min). Ab, In slices exposed to glutamate (Glu 10 M 30 min), short epileptiform discharges elicited by bicuculline (Bic 10 min) were followed by an abrupt appearance of prolonged epileptiform discharges that gradually dominated population responses (Bic 40 min). B, Average durations of epileptiform discharges following continuous bicuculline perfusion in control (ACSF, empty columns) and glutamateexposed slices (filled columns). The average durations of initial epileptiform discharges at Bic 10 min in control and in glutamateexposed slices were not significantly different. In contrast, at Bic 40 min the average duration of the epileptiform discharges in glutamate-exposed slices was significantly longer than that of control slices due to the occurrence of prolonged epileptiform discharges. C, FMRP levels in slices in ACSF, following glutamate exposure (Glu-exposed, before Bic), and after 40 min bicuculline in the recording chamber (Glu-exposed, after 40 min Bic). FMRP in ACSF was 100 Ϯ 3.5%, n ϭ 6; in Glu-exposed, before Bic: 75 Ϯ 3.6%, n ϭ 6; and in Glu-exposed, after 40 min Bic: 102 Ϯ 2.5%; n ϭ 6; one-way ANOVA; **p Ͻ 0.01).
Glutamate exposure alters population responses in the hippocampus Short interictal-like epileptiform discharges (Ͻ1 s) are elicited by application of bicuculline (Bic), a GABA A antagonist, in the hippocampus (Traub and Wong, 1982) . These population responses were examined in slices subjected to vehicle (control) or glutamate exposure (10 M for 30 min). In control experiments, addition of bicuculline consistently elicited short interictal-like epileptiform discharges and the duration of epileptiform discharges remained stable with extended bicuculline perfusion (up to 3 h; Fig. 2Aa ,B, empty columns; in control slices; at Bic 10 min: 398 Ϯ 49 ms; at Bic 40 min: 405 Ϯ 52 ms; n ϭ 8; p ϭ 0.92).
In slices exposed to glutamate, addition of bicuculline first induced short interictal-like epileptiform discharges (Fig. 2Ab, middle  panel) as observed in control slices, but with time prolonged epileptiform discharges of 2-7 s in duration appeared and they ultimately became the dominant population responses (Fig.  2Ab,2B , filled columns; in glutamateexposed slices; at Bic 10 min: 427 Ϯ 40 ms; at Bic 40 min: 4474 Ϯ 394 ms; n ϭ 11; p Ͻ 0.001).
FMRP level was assessed in slices 40 min after bicuculline in the recording chamber. A rebound of FMRP by 25-30% at the 40 min time point was noted (Fig.  2C) . Stimulation of group I mGluRs elicits rapid translation of its target mRNAs including FMRP mRNA (Weiler et al., 1997) . The rebound in FMRP most probably reflects enhanced translation by sustained synaptic activation of group I mGluRs during bicuculline exposure. These results are consistent with those shown in slices treated with DHPG (Zhao et al., 2011) where an initial transient decrease in FMRP, peaking at ϳ10 min, is followed by an increase at 30 min of DHPG exposure.
Group I mGluRs are involved in the activation of prolonged epileptiform discharges
The receptors engaged in the synaptic activation of prolonged epileptiform discharges were examined. In this series of experiments, all slices examined were preexposed to glutamate (10 M for 30 min). Two sets of experiments were performed. First, group I mGluR antagonists (100 M LY367385 and 50 M MPEP) were applied to the slices during glutamate exposure (Fig. 3Aa) . Subsequent application of bicuculline in ACSF no longer caused the appearance of prolonged epileptiform discharges (Fig. 3Aa, middle and right) . Bicuculline induced only short epileptiform discharges that remained stable for the duration of the recordings (up to 3 h; Figs. 3Aa, middle and right, 4C; LY ϩ MPEP; at Bic 10 min: 396 Ϯ 34 ms; at Bic 40 min: 427 Ϯ 33 ms; n ϭ 8; p ϭ 0.51). In a second set of experiments, once prolonged epileptiform discharges were established in slices exposed to glutamate, addition of LY367385 and MPEP suppressed the occurrence of prolonged epileptiform discharges unmasking typical short epileptiform discharges (Figs. 3Ab, middle, 4D; LY ϩ MPEP; control: 4681 Ϯ 440 ms; LY ϩ MPEP: 452 Ϯ 51 ms; n ϭ 6; p Ͻ 0.001). Subsequent washout of the group I mGluR antagonists caused reemergence of prolonged epileptiform discharges (Fig. 3Ab, right) .
Group I mGluRs elicit a number of long-term cellular changes via protein synthesis-dependent processes in the hippocampus (Chuang et al., 2005; Young et al., 2008; ). The engagement of protein synthesis in the induction of prolonged epileptiform discharges was examined by testing whether application of a protein synthesis inhibitor (anisomycin, 20 M) affected the occurrence of prolonged epileptiform discharges in glutamate-exposed slices. Slices were treated with anisomycin Figure 3 . Group I mGluR signaling was required for the induction of prolonged epileptiform discharges. Representative records from glutamate-exposed slices obtained in the presence of group I mGluR antagonists or anisomycin (gray bar). Aa, In the presence of group I mGluR antagonists, 100 M LY367385 and 50 M MPEP (LY ϩ MPEP), bicuculline induced short epileptiform discharges (Bic 10 min) that remained stable (Bic 40 min) for the duration of the recording. Ab, Group I mGluR antagonists (LY ϩ MPEP) were added after perfusion with bicuculline for 40 min. Bicuculline elicited prolonged epileptiform discharges (Bic 40 min). Addition of the Group I mGluR antagonists blocked the prolonged epileptiform discharges unmasking short epileptiform discharges (Bic 60 min). Upon group I mGluR antagonist washout, prolonged epileptiform discharges reappeared and dominated population responses (Bic 90 min). Ba, In the presence of anisomycin (20 M), bicuculline induced short epileptiform discharges (Bic 10 min) but failed to elicit prolonged epileptiform discharges with further perfusion (Bic 40 min). Bb, Once prolonged epileptiform discharges were established following bicuculline application (Bic 40 min), addition of anisomycin did not affect the occurrence of prolonged epileptiform discharges (Bic 90 min). during glutamate exposure and bicuculline application. The duration of short epileptiform discharges recorded under this condition remained stable even with extended perfusion (up to 3 h; Figs. 3Ba, middle and right, 4C, aniso; at Bic 10 min: 418 Ϯ 32 ms; at Bic 40 min: 411 Ϯ 23 ms; n ϭ 8; p ϭ 0.86). In parallel experiments, anisomycin was introduced after prolonged epileptiform discharges were established. In this case, anisomycin had no effect on the duration and frequency of ongoing prolonged epileptiform discharges (Figs. 3Bb, left and right, 4D, aniso; control: 4553 Ϯ 301 ms; anisomycin: 4240 Ϯ 429 ms; n ϭ 6; p ϭ 0.56).
MG-132
B
Glutamate exposure proteolyzes FMRP
Previous studies suggest that downregulation of FMRP is an obligatory step for group I mGluR-mediated protein synthesis and plasticity in wild-type preparations (Hou et al., 2006; Zhao et al., 2011) . FMRP downregulation is mediated by the ubiquitinproteasome system (UPS). The involvement of UPS in FMRP downregulation elicited by glutamate exposure was examined using MG-132, a potent proteasome inhibitor (Lee and Goldberg, 1996) . Slices were treated with MG-132 before (1 M for 45 min) and during glutamate exposure (10 M for 30 min). Western blot results showed that glutamate no longer affected FMRP levels in the presence of MG-132 (glutamate exposure in the presence of MG-132; Fig. 4A ; in MG-312 alone: 100 Ϯ 2%; in MG-312 ϩ Glu: 98 Ϯ 4%; n ϭ 6; p ϭ 0.75).
MG-132 applied during glutamate exposure prevented synaptic activation of prolonged epileptiform discharges. In slices with glutamate exposure in the presence of MG-132, addition of bicuculline elicited stable short epileptiform discharges for the duration of the recordings (up to 3 h; Fig. 4Ba ,C, MG-132; at Bic 10 min: 452 Ϯ 44 ms; at Bic 40 min: 422 Ϯ 49 ms; n ϭ 8; p ϭ 0.65).
Additional data showed that after glutamate exposure and associated FMRP proteolysis, perfusion of MG-132 did not prevent the activation of prolonged epileptiform discharges (Fig. 4Bb,D , MG-132; control: 4485 Ϯ 495 ms; MG-132: 4587 Ϯ 435 ms; n ϭ 6; p ϭ 0.89).
FMRP is the target of the antiepileptogenic action of MG-132
MG-132 affects all cellular proteins subjected to UPS action. Thus, the prevention of prolonged epileptiform discharges could result from changes in any one or more of these proteins. We evaluated the specific role of FMRP downregulation using Fmr1 Ϫ/Ϫ mice. Here, proteasome activity affects all proteins except FMRP, which is absent. Application of MG-132 to Fmr1 Ϫ/Ϫ preparations did not affect the activation of prolonged epileptiform discharges (Fig. 5Ab, right, 
B, Fmr1
Ϫ/Ϫ ; at Bic 40 min: control, 4424 Ϯ 558 ms; MG-132: 4609 Ϯ 804 ms; n ϭ 7; p ϭ 0.84) suggesting that the MG-132 inhibition of prolonged epileptiform discharges is not due to nonspecific actions on cellular proteins other than FMRP.
Discussion
The results of this study suggest that exposure of hippocampal neurons to glutamate altered synaptic responses in the hippocampus to facilitate the activation of group I mGluR-mediated epileptogenesis. Data show that glutamate exposure caused a group I mGluR-mediated proteolysis of FMRP via the ubiquitinproteasome system (Figs. 1, 4A) . Downregulation of FMRP enabled the synaptic induction of prolonged epileptiform discharges via group I mGluR stimulation (Figs. 2, 3Aa, 4C ). The data further indicate that the induction of prolonged epileptiform discharges is a protein synthesis-dependent process (Figs. 3Ba, 4C) subjected to FMRP regulation and that prolonged epileptiform discharges, once induced, are maintained by endogenous group I mGluR activities (Fig. 3Bb) .
FMRP regulation of prolonged epileptiform discharges
In the hippocampus, the constitutive level of neuronal FMRP is sufficient to arrest group I mGluR-activated translation (Zhao et al., 2011) . Because of the regulatory action of FMRP, synaptic stimulation in hippocampal circuits does not normally elicit prolonged epileptiform discharges that require de novo protein synthesis for their production. Such discharges are only elicited in fragile X syndrome model mouse preparations where FMRP is absent (Chuang et al., 2005) . . MG-132 failed to block the induction of prolonged epileptiform discharges in glutamate-exposed Fmr1 Ϫ/Ϫ slices. Slices were prepared from Fmr1 Ϫ/Ϫ mice and subjected to glutamate exposure and bicuculline perfusion. Aa, In control experiments, bicuculline elicited prolonged epileptiform discharges (Bic 40 min, average duration: 4424 Ϯ 558 ms) following a brief appearance of short epileptiform discharges (Bic 10 min, average duration: 392 Ϯ 53 ms; n ϭ 7; p Ͻ 0.001). Ab, Slices were treated with MG-132 (gray bar) before and during glutamate exposure and bicuculline perfusion. Unlike that observed in wild-type glutamate-exposed slices (Fig. 4Ba) , MG-132 was no longer effective in blocking the induction of prolonged epileptiform discharges and bicuculline induced prolonged epileptiform discharges (Bic 40 min) after the initial short epileptiform discharges (Bic 10 min). B, Summary data of the average duration of the epileptiform discharges induced by bicuculline in wild-type and Fmr1 Ϫ/Ϫ glutamate-exposed slices in the absence (empty columns) or presence (filled columns) of MG-132. MG-132 blocked the induction of prolonged epileptiform discharges in wild-type, but not in Fmr1 Ϫ/Ϫ , preparations.
Activation of group I mGluRs elicits parallel responses: signaling cascades for protein synthesis and, in tandem, proteolysis of FMRP in wild-type neurons (Hou et al., 2006; Zhao et al., 2011; Nalavadi et al., 2012) . Group I mGluRs are stimulated by recurrent synapses between CA3 pyramidal cells (Lee et al., 2002) . Our data suggest that stimulation of group I mGluRs through synchronized activation of these recurrent synapses in the presence of bicuculline is not sufficient to elicit FMRP downregulation and thus allow for the group I mGluR-mediated protein synthesis necessary for prolonged epileptiform discharge activation. In contrast, during glutamate exposure, more persistent and tonic stimulation of group I mGluRs causes sufficient FMRP proteolysis to enable induction of prolonged epileptiform discharges during synaptic stimulation (Figs. 1, 2) . Downregulation of FMRP during glutamate exposure is dependent on group I mGluR activation and subsequent UPSmediated proteolysis. Inhibition either of group I mGluRs or of proteasome activity blocked FMRP downregulation and prevented the induction of prolonged epileptiform discharges (Figs.  3A, 4) . The ineffectiveness of proteasome inhibitor on the induction of prolonged epileptiform discharges in Fmr1 Ϫ/Ϫ slices ( Fig.  5 ) points to the importance of FMRP preservation from proteolysis by proteasome inhibitor as the response guarding against prolonged epileptiform discharge activation. It remains possible that glutamate exposure also affects the stability of some proteins associated with FMRP signaling, such as AGO1-miR-125a inhibitory complex (Muddashetty et al., 2011) , which also regulates translation. Accordingly, an alternative explanation for the ineffectiveness of proteasome inhibitor in Fmr1 Ϫ/Ϫ preparation is that these other protein(s) are constitutively downregulated in Fmr1 Ϫ/Ϫ neurons so that they are not at a sufficient level to effectively regulate translation in the Fmr1 Ϫ/Ϫ preparation. Upon glutamate exposure, FMRP is quickly degraded and then becomes stable at a reduced level of ϳ70% of control even with extended exposure time or increased glutamate concentration. These results suggest that FMRP proteolysis by glutamate is a saturatable process. This finding is consistent with that observed in a previous study in slices treated with group I mGluR agonist DHPG (Zhao et al., 2011) where a stable level of FMRP is retained at 72%. Other studies have shown that group I mGluR stimulation elicits a rapid FMRP dephosphorylation, a step required for subsequent UPS-mediated proteolysis (Nalavadi et al., 2012) . Thus, it is possible that the upper limit of glutamateinduced proteolysis in FMRP level may be set by the amount of FMRP available for the dephosphorylation process elicited by group I mGluR activation.
Induction and maintenance of prolonged epileptiform discharges
Induction of group I mGluR-mediated prolonged epileptiform discharges involves the long-term activation of several excitatory cellular responses in CA3 pyramidal cells (Chuang et al., 2005; Young et al., 2008; ). These include suppression of the spike afterhyperpolarization, activation of a voltagedependent inward current (I mGluR(V) ), and increase in cellular input resistance. Long-term activation of these cellular responses by group I mGluR stimulation is critically dependent on de novo protein synthesis . When protein synthesis is blocked pharmacologically by anisomycin, excitatory responses are elicited transiently upon receptor stimulation but are not maintained (Young et al., 2008 (Young et al., , 2013 ). Similarly, in the presence of protein synthesis inhibitors, synaptic stimulation no longer elicited prolonged epileptiform discharges in glutamate-exposed slices (Figs. 3B, 4C) . A question that can be asked is how does group I mGluR-induced protein synthesis cause the excitatory responses to become persistently active (long-term activation)? Data reveal that the protein synthesisdependent process changes the properties of group I mGluRs such that the receptors themselves become constitutively active (Lodge et al., 2013; Young et al., 2013) . Thus, following induction, constitutively active group I mGluRs continually elicit longterm activation of excitatory cellular responses without requiring ligand-mediated activation (Lodge et al., 2013; Young et al., 2013) .
Because of the involvement of constitutively active receptors, maintenance of all group I mGluR excitatory cellular responses are reversibly blocked by group I mGluR antagonists. Previous data show that prolonged epileptiform discharges directly activated by group I mGluR agonists are sustained by the concerted action of persistent excitatory cellular responses Young et al., 2013) . The finding that synaptically induced prolonged epileptiform discharges in glutamate-exposed slices were also reversibly blocked by group I mGluR antagonists (Fig.  3Ab) is consistent with the hypothesis that group I mGluRs play a role both in the induction and maintenance of these discharges.
In sum, the results suggest the following scheme for the effects of glutamate exposure: downregulation of FMRP in glutamate enables group I mGluR-mediated protein synthesis to facilitate the generation of prolonged epileptiform discharges that are sustained by excitatory cellular responses activated by endogenous group I mGluR activity.
Excessive glutamate exposure is an initial brain insult commonly seen in stroke, status epilepticus (SE), and traumatic brain injury (TBI). Data suggested that overstimulation of glutamate receptors is a contributor to the development of recurrent epileptic seizures (for review, see McNamara et al., 2006) . The in vitro results here suggest that glutamate exposure facilitates the emergence of group I mGluR-mediated epileptiform discharges. Our results do not provide any indication of whether such responses are elicited in vivo upon glutamate exposure. The data do suggest that the integrity of FMRP is a point of vulnerability that is compromised upon glutamate exposure and is thus a candidate site to be evaluated for long-term effects of glutamate exposure including epileptogenesis.
